Anti biotic-associated diarrhea: epidemiology, trends and treatment

被引:226
作者
McFarland, Lynne V. [1 ,2 ]
机构
[1] Puget Sound Vet Adm, Dept Hlth Serv Res & Dev, Seattle, WA 98101 USA
[2] Univ Washington, Dept Med Chem, Sch Pharm, Seattle, WA 98101 USA
关键词
antibiotic-associated diarrhea; antibiotic complications; Clostridium difficile; colitis; diarrhea; epidemiology; probiotics; risk factors;
D O I
10.2217/17460913.3.5.563
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A common complication of antibiotic use is the development of gastrointestinal disease. This complication ranges from mild diarrhea to pseudomembranous colitis. Outbreaks of antibiotic-associated diarrhea (AAD) may also occur in healthcare settings, usually caused by Clostridium difficile. AAD typically occurs in 5-35% of patients taking antibiotics and varies depending upon the specific type of antibiotic, the health of the host and exposure to pathogens. The pathogenesis of AAD may be mediated through the disruption of the normal microbiota resulting in pathogen overgrowth or metabolic imbalances. The key to addressing AAD is prompt diagnosis followed by effective treatment and institution of control measures. Areas of active research include the search for other etiologies and more effective treatments.
引用
收藏
页码:563 / 578
页数:16
相关论文
共 106 条
  • [61] Implications of the changing face of Clostridium difficile disease for health care practitioners
    McFarland, Lynne V.
    Beneda, Henry W.
    Clarridge, Jill E.
    Raugi, Gregory J.
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2007, 35 (04) : 237 - 253
  • [62] McFarland Lynne V., 2000, Microbial Ecology in Health and Disease, V12, P193, DOI 10.1080/08910600050216183
  • [63] Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea
    McPherson, Stuart
    Rees, Colin J.
    Ellis, Richard
    Soo, Shelly
    Panter, Simon J.
    [J]. DISEASES OF THE COLON & RECTUM, 2006, 49 (05) : 640 - 645
  • [64] Empirical use of antibiotics and adjustment of empirical antibiotic therapies in a university hospital: a prospective observational study
    Mettler, Julian
    Simcock, Mathew
    Sendi, Pedram
    Widmer, Andreas F.
    Bingisser, Roland
    Battegay, Manuel
    Fluckiger, Ursula
    Bassetti, Stefano
    [J]. BMC INFECTIOUS DISEASES, 2007, 7 (1)
  • [65] MODENA S, 2007, INFECT CONT HOSP EP, V26, P685
  • [66] Recent advances in Clostridium difficile-associated disease
    Monaghan, T.
    Boswell, T.
    Mahida, Y. R.
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2009, 85 (1001) : 152 - 162
  • [67] Annual incidence of MRSA falls in England, but C difficile continues to rise, report shows
    Mooney, Helen
    [J]. BRITISH MEDICAL JOURNAL, 2007, 335 (7627): : 958 - 958
  • [68] Clostridium diffidle-associated diarrhea in heart transplant recipients:: Is hypogammaglobulinemia the answer?
    Munoz, Patricia
    Giannella, Maddalena
    Alcala, Luis
    Sarmiento, Elisabeth
    Yanez, Juan Fernandez
    Palomo, Jesus
    Catalan, Pflar
    Carbone, Javier
    Bouza, Emilio
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (09) : 907 - 914
  • [69] Clostridium difficile colitis that fails conventional metronidazole therapy:: response to nitazoxanide
    Musher, Daniel M.
    Logan, Nancy
    Mehendiratta, Vaibhav
    Melgarejo, Nicolas A.
    Garud, Sagar
    Hamill, Richard J.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (04) : 705 - 710
  • [70] A large outbreak of Clostridium Difficile -: Associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use
    Muto, CA
    Pokrywka, M
    Shutt, K
    Mendelsohn, AB
    Nouri, K
    Posey, K
    Roberts, T
    Croyle, K
    Krystofiak, S
    Patel-Brown, S
    Pasculle, AW
    Paterson, DL
    Saul, M
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2005, 26 (03) : 273 - 280